top of page

de novo

ventures

"of new" 

venture capital

Home
BUILDING GREAT TECHNOLOGY COMPANIES

100%

All of our portfolio companies are thriving and growing

>4x

Return on investments 

ABOUT
PROJECTS

LATEST
INVESTMENTS

CAPSULASER
Selective laser capsulotomy

Enhancing sight

ALPHAEON CREDIT

 

Enhancing patient financing

MILO
The Action Communicator 

Enhancing communication

OUR ETHOS

CUSTOMER
FOCUS

We never forget that our portfolio companies are here to serve their customers and always be guided by their moral compass.

PRIDE IN EXCELLENCE

We set a high bar and sweat the details. Holding ourselves accountable and always striving for excellence through continual improvement.

WINNING CULTURE

We support our companies until they succeed.

We are focused on:

winning products

+ winning teams

= winning results 

SERVICES
THE TEAM

PORTFOLIO

ALPHA_Credit_logo_trans.jpg
CAPSULASER logo.JPG
evolus.JPG

IPO(NASDAQ): EOLS

Zelegent logo.JPG
Aeon logo.JPG
describe.JPG

Acquired by Merz

OPTIMEDICA

PRECISIONLIGHT

Sold twice:

+ Cataract division acquired by Abbot now part of J&J Vision

+ Retina division acquired by Topcon 

Acquired by Allegan

now part of Abbvie

OUR DNA

de novo ventures has a long history of world-class entrepreneur expertise. All the de novo team have built great companies as executive management, upon successful exit the CEOs and founders of our portfolio companies are invited to be part of de novo ventures. This brings real-world experience to creating the "next" great technology companies.

David%2520in%2520his%2520E-type_edited_e

Dave Mordaunt PhD

Managing Director

OUR DBA
bottom of page